RAC

1.11%

$1.83 race oncology ltd

RAC - Charts & Price Action, page-6971

First 6971 Last

Share
Profile

Follow
jsbuser

4,443 Posts.

1829

14/07/21

09:29

Post #: 54484925
Share

Originally posted by Mason14 ↑

Always enjoy your posts, @W3Booster. Thank you for your time.

I'm seeing a symmetrical triangle play out on the daily and a cup and handle on the weekly. I don't put a lot of weight into my charting skills and much prefer FA to drive my thoughts on price movements (probably why I'm useless at entries). As such, I suspect that it will not be long before we see the upper resistance levels broken and all time high cleared.

There are many lines of evidence that I draw from to come to this conclusion, like the baseline valuation I completed not long ago indicating that other first-in-class or best-in-class drugs achieved an average buyout price of AUS $9.4B ($55 ps; 170M SOI). I also consider the massive amount of FTO-directed preclinical and clinical data to come out over the next 12 months.

What I have not discussed is when I think the City of Hope 2.0 paper will be released to market. Having looked through Jianjun Chen's published papers (1), I picked out papers that seemed to follow on from the last. My estimation is that we can expect the City of Hope 2.0 paper around September, which is about 6 weeks away from the current date. Clearly, the actual release data may be earlier or later than this estimate. The original City of Hope paper that discovered Bisantrene was extremely detailed and of remarkable quality, and so I expect the second one to match that.

I believe that the next run may be the longest and largest, as it will coincide directly with independent research completed by an internationally recognised research group, 7 FTO-directed preclinical programs, and 4 clinical programs with a focus on FTO expression or MoA. Those who have invested more because they recognise the amount of data about to be generated over the next 12-18 months and the likelihood of FTO inhibition in historic clinical data are setting themselves up very nicely in my opinion (It's exactly what I am doing).

1 https://www.cityofhope.org/people/jianjun-chen

Expand

I agree on your chart Mason. I wont be surprised if it hits the bottom of the triangle today and then we find whether support or resistance is strongest. Its a classic wait for news drift down with OBV holding pretty steady really and only slightly negative with low volume. Short channel has levelled out as well and the WPO has held steady with low oscillation. Compare it to the big shifts in March.

RAC Price at posting: $3.57 Sentiment: Buy Disclosure: Held
17 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce's R327 found effective against E.coli during clinical trial

3DP

Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Microcap Wrap: 5 explorers with news out today

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

There are more pages in this discussion • 14,549 more messages in this thread...

First 6971 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.83		Change 0.020(1.11%)		Mkt cap ! $310.7M

Open	High	Low	Value	Volume
$1.81	$1.83	$1.79	$142.0K	78.77K

Buyers (Bids)

No.	Vol.	Price($)
1	500	$1.81

Sellers (Offers)

Price($)	Vol.	No.
$1.83	641	1

View Market Depth

No.	Vol.	Price($)
1	500	1.810
3	7009	1.790
1	450	1.780
1	651	1.775
3	17043	1.770

Price($)	Vol.	No.
1.825	641	1
1.830	1209	2
1.835	651	1
1.840	4651	3
1.845	2746	1

Last trade - 16.10pm 28/06/2024 (20 minute delay)

RAC (ASX) Chart

RAC - Charts & Price Action, page-6971

Recce's R327 found effective against E.coli during clinical trial

Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Microcap Wrap: 5 explorers with news out today

Ava Risk Group expands US presence with A$0.7M Substation Deal

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

RAC - Charts & Price Action, page-6971

Top Stories

Recce's R327 found effective against E.coli during clinical trial

Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Microcap Wrap: 5 explorers with news out today

Ava Risk Group expands US presence with A$0.7M Substation Deal

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News